BRODNEY, MICHAEL AARON,布罗尼 麦可,布羅尼 麥可,BUTLER, CHRISTOPHER RYAN,布特勒 克里斯多夫,布特勒 克里斯多夫,BECK, ELIZABETH MARY,贝克 伊莉莎白,貝克 伊莉莎白,DAVOREN, JENNIFER ELIZABETH,达威伦 珍妮佛,達威倫 珍妮佛,LACHAPELLE, ERIK ALPHIE,拉奇佩利 艾瑞克,拉奇佩利
申请号：
TW103104416
公开号：
TW201443064A
申请日:
2014.02.11
申请国别(地区):
TW
年份:
2014
代理人:
摘要：
The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1 and R2 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.本發明關於化合物、互變異構物及所揭示化合物的醫藥上可接受之鹽,其中該化合物具有式I之結構,且變數R1和R2係如說明書中所定義。本發明亦揭示對應之醫藥組成物、治療方法、合成方法及中間物。
